Impact of Value-Based Payment Models on Chronic Disease Management Outcomes: A Health Economics Evaluation
DOI:
https://doi.org/10.5281/zenodo.22656358Keywords:
value-based payment, accountable care organizations, bundled payments, chronic disease management, health economics evaluationAbstract
Background: Fee-for-service reimbursement rewards service volume rather than the coordinated, longitudinal care that chronic
diseases such as diabetes, cardiovascular disease, and chronic obstructive pulmonary disease require, prompting adoption of
value-based payment (VBP) models intended to realign financial incentives toward cost and quality. Objective: This case study
synthesizes health economics evidence on the impact of major VBP models - accountable care organizations (ACOs), global-budget
contracts, condition-based bundled payments, and pay-for-performance (P4P) programs - on chronic disease management cost,
quality, and care coordination outcomes. Methods: We conducted a case-based narrative synthesis of peer-reviewed evaluations of
purposively selected, well-documented programs spanning the major VBP model types, including the Medicare Shared Savings
Program, the Massachusetts Alternative Quality Contract, the Medicare Bundled Payments for Care Improvement initiative, the UK
Quality and Outcomes Framework, and enhanced primary-care payment models; each source was individually verified against its
publisher or bibliographic record before inclusion. Findings: VBP models produced modest but consistent reductions in low-value
utilization, concentrated in post-acute and outpatient care, with savings that grew over multi-year program duration under
stronger, two-sided risk arrangements. Evidence for improvement in incentivized process-of-care measures for diabetes,
cardiovascular disease, and COPD was more consistent than evidence for corresponding reductions in mortality or major morbidity,
and programs relying on financial incentives alone without dedicated care-coordination investment showed weaker results.
Distributional analyses indicated that imperfect risk adjustment can disadvantage providers serving socioeconomically vulnerable
chronic disease populations. Conclusions: Value-based payment can meaningfully reduce low-value utilization and improve
process-of-care quality for chronic disease populations, but realizing durable clinical benefit requires sustained multi-year
accountability, explicit investment in care-coordination infrastructure, and deliberate attention to social-risk adjustment rather
than reliance on the payment mechanism alone.
References
Rosenthal MB, Frank RG (2006) What is the empirical basis for paying for quality in health care? Medical Care Research and Review, 63(2):135-157, DOI:10.1177/1077558705285291.
Song Z, Safran DG, Landon BE, He Y, Ellis RP, Mechanic RE, Day MP, Chernew ME (2012) The 'Alternative Quality Contract,' based on a global budget, lowered medical spending and improved quality. Health Affairs, 31(8):1885-1894, DOI:10.1377/hlthaff.2012.0327.
Struijs JN, Baan CA (2011) Integrating care through bundled payments - lessons from the Netherlands. New England Journal of Medicine, 364(11):990-991, DOI:10.1056/NEJMp1011849.
Markovitz AA, Ryan AM (2017) Pay-for-performance: disappointing results or masked heterogeneity? Medical Care Research and Review, 74(1):3-78, DOI:10.1177/1077558715619282.
McWilliams JM, Hatfield LA, Chernew ME, Landon BE, Schwartz AL (2016) Early performance of accountable care organizations in Medicare. New England Journal of Medicine, 374(24):2357-2366, DOI:10.1056/NEJMsa1600142.
Doran T, Fullwood C, Gravelle H, Gudex C, Hiroeh U, Hutchings A, Kristensen K, Roland M (2006) Pay-for-performance programs in family practices in the United Kingdom. New England Journal of Medicine, 355(4):375-384, DOI:10.1056/NEJMsa055505.
Dale SB, Ghosh A, Peikes DN, Day TJ, Yoon FB, Taylor EF, Swankoski K, O'Malley AS, Conway PH, Rajkumar R, Press MJ, Sessums L, Brown R (2016) Two-year costs and quality in the Comprehensive Primary Care Initiative. New England Journal of Medicine, 374(24):2345-2356, DOI:10.1056/NEJMsa1414953.
Lemak CH, Nahra TA, Cohen GR, Erb ND, Paustian ML, Share D, Hirth RA (2015) Michigan's fee-for-value physician incentive program reduces spending and improves quality in primary care. Health Affairs, 34(4):645-652, DOI:10.1377/hlthaff.2014.0426.
McWilliams JM, Landon BE, Chernew ME (2013) Changes in health care spending and quality for Medicare beneficiaries associated with a commercial ACO contract. JAMA, 310(8):829-836, DOI:10.1001/jama.2013.276302.
Song Z, Ji Y, Safran DG, Chernew ME (2019) Health care spending, utilization, and quality 8 years into global payment. New England Journal of Medicine, 381(3):252-263, DOI:10.1056/NEJMsa1813621.
Joynt Maddox KE, Orav EJ, Zheng J, Epstein AM (2018) Evaluation of Medicare's bundled payments initiative for medical conditions. New England Journal of Medicine, 379(3):260-269, DOI:10.1056/NEJMsa1801569.
Rolnick JA, Liao JM, Emanuel EJ, Huang Q, Ma X, Shan EZ, Dinh C, Zhu J, Wang E, Cousins D, Navathe AS (2020) Spending and quality after three years of Medicare's bundled payments for medical conditions: quasi-experimental difference-in-differences study. BMJ, 369:m1780, DOI:10.1136/bmj.m1780.
Ryan AM, Krinsky S, Kontopantelis E, Doran T (2016) Long-term evidence for the effect of pay-for-performance in primary care on mortality in the UK: a population study. Lancet, 388(10041):268-274, DOI:10.1016/S0140-6736(16)00276-2.
Kontopantelis E, Springate DA, Ashworth M, Webb RT, Buchan IE, Doran T (2015) Investigating the relationship between quality of primary care and premature mortality in England: a spatial whole-population study. BMJ, 350:h904, DOI:10.1136/bmj.h904.
Mendelson A, Kondo K, Damberg C, Low A, Motuapuaka M, Freeman M, O'Neil M, Relevo R, Kansagara D (2017) The effects of pay-for-performance programs on health, health care use, and processes of care: a systematic review. Annals of Internal Medicine, 166(5):341-353, DOI:10.7326/M16-1881.
Petersen LA, Woodard LD, Urech T, Daw C, Sookanan S (2006) Does pay-for-performance improve the quality of health care? Annals of Internal Medicine, 145(4):265-272, DOI:10.7326/0003-4819-145-4-200608150-00006.
Kondo KK, Damberg CL, Mendelson A, Motu'apuaka M, Freeman M, O'Neil M, Relevo R, Low A, Kansagara D (2016) Implementation processes and pay for performance in healthcare: a systematic review. Journal of General Internal Medicine, 31(Suppl 1):61-69, DOI:10.1007/s11606-015-3567-0.
Kaufman BG, Spivack BS, Stearns SC, Song PH, O'Brien EC (2019) Impact of accountable care organizations on utilization, care, and outcomes: a systematic review. Medical Care Research and Review, 76(3):255-290, DOI:10.1177/1077558717745916.
de Bruin SR, Baan CA, Struijs JN (2011) Pay-for-performance in disease management: a systematic review of the literature. BMC Health Services Research, 11:272, DOI:10.1186/1472-6963-11-272.
de Bruin SR, Heijink R, Lemmens LC, Struijs JN, Baan CA (2011) Impact of disease management programs on healthcare expenditures for patients with diabetes, depression, heart failure or chronic obstructive pulmonary disease: a systematic review of the literature. Health Policy, 101(2):105-121, DOI:10.1016/j.healthpol.2011.03.006.
Roberts ET, Zaslavsky AM, McWilliams JM (2018) The value-based payment modifier: program outcomes and implications for disparities. Annals of Internal Medicine, 168(4):255-265, DOI:10.7326/M17-1740.
Ryan AM (2013) Will value-based purchasing increase disparities in care? New England Journal of Medicine, 369(26):2472-2474, DOI:10.1056/NEJMp1312654.
